* Sent from my Apple iPhone
Begin forwarded message:
From: "Money and Markets" <eletter@e.moneyandmarkets.com>
Date: 28 July, 2011 4:33:01 AM PDT
Subject: How to Invest in the Fountain of Youth
Reply-To: Do-Not-Reply@e.moneyandmarkets.com
View Our Website [»] Archives [»] Follow us on Twitter
YOUR BEST SOURCE FOR THE UNBIASED MARKET COMMENTARY YOU WON'T GET FROM WALL STREET
How to Invest in the Fountain of Youth
by Ron Rowland
Thrursday, July 28, 2011 at 7:30am
Like many of you, I'm a Baby Boomer. Now I find myself north of 50 and the prospect of getting "old" isn't very attractive.
What does this have to do with investing and ETFs? Plenty!
Social and demographic trends eventually show up in the financial markets. The post-war generation's passage into retirement age is driving growth for a certain sector. Today I'll describe that sector, and then list some ETFs that will help you participate.
The Fountain of Youth
Humans have sought eternal youth for thousands of years. Ancient stories describe Alexander the Great crossing a vast desert in search of a spring whose waters would reverse aging. The Spanish explorer Ponce de Leon may have been looking for the same thing when he discovered Florida in the 16th century.
He wanted the Fountain of Youth, but found Florida instead. There's no evidence any such fountain ever existed, but people still seek it today. Baby Boomers are particularly resistant to riding quietly into the sunset. Many of us want to hold on to youth as long as we can.
When consumers want something bad enough, capitalism usually obliges. The biotechnology industry's explosive growth in the last two decades was no accident ... and I think it's only just beginning.
As I described in my 2009 column, Get on the Biotech Bandwagon with ETFs, modern genetics are the key to unlocking the real fountain of youth. The resulting biotechnology hasn't made us any younger ... but it helps us not feel so old!
Hidden Asian Gems Await
Tony Sagami's latest video is critical to growing your wealth. In it, Tony and Larry Edelson discuss the biggest mega-forces impacting the global economy today. Plus, Tony reviews three triple-your-money opportunities and 15 more investments on his radar screen right now.
But we simply can't keep it online past this Sunday. So if you haven't already seen the online presentation or want to watch it again, be sure to do so right away.
The demographic trend is this sector's friend. By 2020, the world will have more than 1 billion people age 60+. Those in the developed world (a group that by 2020 will include China) control vast wealth. How will they spend it? By searching for that same elusive fountain.
Baby Boomers are pouring their capital into the best medical treatments money can buy. They aren't just after longer life; they want better life. They want cures for whatever stands in the way of an active retirement. Cancer, heart disease, obesity, arthritis, wrinkles, you name it: Scientists are working on expensive treatments for well-heeled patients.
Genetic research may lead to a real fountain of youth. Is eternal youth really a reasonable expectation? No, of course not. Nevertheless, this generation grew up watching men travel to the moon. They received polio vaccines and saw smallpox wiped off the map. If they think any challenge can be overcome with enough cash and effort ... well, it's hard to blame them.
Biotech Thrives
Even in CrisisAll well and good, you might say, but we live in tough times. Can health care in general, and particularly biotechnology, keep flying into the wind?
Yes, it can, and here's why:
Some very wealthy people will gladly spend almost any amount of money to extend their lives. Once they do, the knowledge gained in the endeavor doesn't just disappear. It spreads quickly. Then the price starts to drop. The new treatments become available everywhere.
The rich guy who financed the initial research? He got what he wanted. If his investment lets other people live longer, too, then he did a good thing.
All this remains true whether the economy is in boom, bust, recession or depression. Will biotech have ups and downs? Of course. But as long as people want more years and better lives, this sector will have a bright future.
ETFs: Custom-Made for Biotech
You can, of course, jump into any number of biotech stocks that are pursuing some kind of breakthrough. Unfortunately, many will fail. The key is to have a diversified portfolio so the winners offset the losers.
And how do you accomplish this? ETFs, of course! With a sector ETF, you can have instant access to an entire index of biotech stocks. I think this approach is far better than trying to pick stocks.
Here are some biotech-oriented ETFs you may want to consider:
- iShares Nasdaq Biotechnology (IBB)
- SPDR S&P Biotech (XBI)
- First Trust NYSE Arca Biotechnology (FBT)
- PowerShares Dynamic Biotech and Genome (PBE)
- ProShares Ultra Nasdaq Biotechnology (BIB)
My personal favorite is XBI. The others have their attractions as well, though, so make your own decision. Note that BIB has 2X daily leverage and is consequently more volatile than the others.
Social Security Cuts Are "On the Table" ...
Washington lawmakers are considering changes to Social Security that will mean deeper and deeper benefit cuts.
So In this video, our income investment expert shows you how to secure safe, growing income streams in your golden years.
Secure Your Growing Retirement Income Streams Right Now By Using this Secret Strategy! Click to here to watch it now.
For those times when biotech is retreating, you can also get 2X inverse leverage in ProShares UltraShort Nasdaq Biotechnology (BIS). That means you stand to make 2 percent for each 1 percent drop in the Nasdaq Biotechnology Index. So this ETF can be used as either a speculative inverse trade, or to temporarily hedge your longer-term biotech positions.
And for clear, concise alerts on when to get into an ETF — and when to get out — you may be interested in my International ETF Trader service. Watch my latest video here.
Biotech isn't right for everyone, of course. But if you have a long-term perspective and are willing to ride out the dips, the potential is huge.
Best wishes,
Ron
History Is Repeating Itself in the Currency Markets
The U.S. dollar is growing weaker every day, driven by inflation caused by irresponsible borrowing and money printing by the Federal Reserve. Kevin Kerr says that the dollar will collapse just like another once-powerful currency: the Roman dinar.
Click here to view [»]
Whatever you do, DO NOT make this costly blunder when investing overseas!
Discover why using ordinary mutual funds to invest overseas could be a costly mistake.
[More »]Why hasn't Wall Street told you about this before?
A special series of reports dedicated exclusively to dividend opportunities — that you can start enjoying right now!
[More »]A Safe Port in a Stormy Stock Market
The broad stock market is running scared as Washington goes into deadlock over the debt ceiling. But one area of the stock market is doing very well ...
[More »]Three Triple-Your-Money Opportunities
Tony Sagami and Larry Edelson give you their urgent forecasts from the front line in Asia ...
[More »]The dollar is following a well-worn path of destruction
The mighty U.S. dollar's fall from economic grace didn't happened overnight. It's been a long and painful process driven by bad judgment, irresponsible fiscal policies, and arrogance ...
[More »]
UNCOMMON WISDOM
China's Transformation Into A Consumer-Driven Economy
by Tony Sagami
It is an old statistic but one that investors should never forget: Roughly 70% of the U.S. economy is comprised of consumer spending ...
[ More » ]
If you're in the market or own a home, you don't want to miss this...
I have a very urgent message for you.
An acclaimed economy researcher who's predicted nearly every major economic trend over the past 30 years…including the 1991 recession, Japan's lost decade, the 2001 tech crash, the bull market and housing boom of the last decade and, most recently, the credit and housing bubble of 2008.
But wait until you hear what he's forecast for the coming months. The scary thing is, it's already starting to happen.
Details here.
About Money and Markets
For more information and archived issues, visit http://www.moneyandmarkets.com
Money and Markets is a free daily investment newsletter published by Weiss Research, Inc. This publication does not provide individual, customized investment or trading advice. All information is based upon data whose accuracy is deemed reliable, but not guaranteed. Performance returns cited are derived from our best estimates, but hypothetical as we do not track actual prices of customer purchases and sales. We cannot guarantee the accuracy of third party advertisements or sponsors, and these ads do not necessarily express the viewpoints of Money and Markets or its editors. For more information, see our Terms and Conditions. View our Privacy Policy. Would you like to unsubscribe from our mailing list? To make sure you don't miss our urgent updates, just follow these simple steps to add Weiss Research to your address book.Attention editors and publishers! Money and Markets content may be republished with a link to the full story on MoneyandMarkets.com. Such republication must include attribution with a link to the MoneyandMarkets home page as follows: "Source: http://www.moneyandmarkets.com"
Weiss Research, Inc. | 15430 Endeavour Dr. | Jupiter, FL 33478 | 1-800-291-8545
